[
    [
        {
            "time": "",
            "original_text": "三家国内IVD械企净利润超20亿",
            "features": {
                "keywords": [
                    "IVD",
                    "械企",
                    "净利润",
                    "20亿"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "三家国内IVD械企净利润超20亿",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "健帆生物跌7.9% 上月初安信证券国泰君安唱多",
            "features": {
                "keywords": [
                    "健帆生物",
                    "跌",
                    "7.9%",
                    "安信证券",
                    "国泰君安",
                    "唱多"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "健帆生物跌7.9% 上月初安信证券国泰君安唱多",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 6,
                "Impact": 7,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "高瓴资本概念股普遍调整，健帆生物、凯莱英、广联达、国瓷材料、泰格医药领跌",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "概念股",
                    "调整",
                    "健帆生物",
                    "凯莱英",
                    "广联达",
                    "国瓷材料",
                    "泰格医药",
                    "领跌"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "高瓴资本概念股普遍调整，健帆生物、凯莱英、广联达、国瓷材料、泰格医药领跌",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]